|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
150+ minutes | 0-149 minutes | Don’t know/Not Sure/Refused/Missing | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 4,088 | 2,021 | 49.2 | 47.0-51.3 | 1,394 | 32.9 | 30.9-35.0 | 673 | 17.9 | 16.3-19.6 |
| GENDER | ||||||||||
| Male | 1,803 | 968 | 52.0 | 48.8-55.2 | 562 | 31.3 | 28.4-34.3 | 273 | 16.7 | 14.4-19.3 |
| Female | 2,285 | 1,053 | 46.6 | 43.7-49.5 | 832 | 34.5 | 31.7-37.3 | 400 | 18.9 | 16.7-21.3 |
| Have Health Insurance | ||||||||||
| Yes | 3,699 | 1,868 | 50.0 | 47.7-52.3 | 1,250 | 32.8 | 30.7-35.0 | 581 | 17.2 | 15.5-19.1 |
| No | 319 | 126 | 42.1 | 35.2-49.4 | 120 | 35.3 | 29.0-42.2 | 73 | 22.5 | 17.1-29.1 |
| Body Mass Index | ||||||||||
| Underweight | 66 | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 1,019 | 586 | 55.2 | 50.9-59.5 | 293 | 29.8 | 25.8-34.0 | 140 | 15.0 | 12.2-18.2 |
| Overweight | 1,311 | 735 | 56.2 | 52.3-60.0 | 399 | 29.1 | 25.7-32.7 | 177 | 14.8 | 12.2-17.7 |
| Obese | 1,326 | 540 | 41.4 | 37.6-45.2 | 526 | 37.4 | 33.8-41.1 | 260 | 21.2 | 18.2-24.6 |
| Current Smoker | ||||||||||
| Yes | 485 | 187 | 36.8 | 30.5-43.6 | 213 | 44.2 | 37.6-51.0 | 85 | 19.0 | 14.1-25.1 |
| No | 3,454 | 1,768 | 51.5 | 49.2-53.8 | 1,123 | 30.9 | 28.8-33.1 | 563 | 17.6 | 15.9-19.4 |
| History of CVD** | ||||||||||
| Yes | 437 | 172 | 38.9 | 32.4-45.7 | 199 | 42.5 | 35.9-49.4 | 66 | 18.6 | 13.1-25.7 |
| No | 3,625 | 1,839 | 50.3 | 48.0-52.6 | 1,185 | 31.9 | 29.8-34.1 | 601 | 17.8 | 16.1-19.6 |
| Binge Drinker | ||||||||||
| Yes | 463 | 253 | 53.6 | 47.5-59.7 | 134 | 28.8 | 23.5-34.8 | 76 | 17.6 | 13.5-22.6 |
| No | 3,324 | 1,629 | 48.9 | 46.5-51.4 | 1,148 | 33.4 | 31.2-35.8 | 547 | 17.6 | 15.8-19.5 |
| Heavy Drinker | ||||||||||
| Yes | 194 | 101 | 49.0 | 39.4-58.7 | 61 | 26.4 | 19.5-34.7 | 32 | 24.6 | 16.5-35.0 |
| No | 3,601 | 1,783 | 49.6 | 47.3-51.9 | 1,222 | 33.0 | 30.8-35.2 | 596 | 17.4 | 15.8-19.3 |
| COPD | ||||||||||
| Yes | 322 | 106 | 31.6 | 24.8-39.3 | 161 | 53.6 | 45.5-61.6 | 55 | 14.8 | 10.5-20.5 |
| No | 3,751 | 1,913 | 50.7 | 48.5-53.0 | 1,225 | 31.3 | 29.2-33.4 | 613 | 18.0 | 16.3-19.8 |
| Current Asthma | ||||||||||
| Yes | 440 | 164 | 39.7 | 32.8-47.0 | 190 | 44.1 | 37.0-51.4 | 86 | 16.3 | 12.3-21.2 |
| No | 3,629 | 1,848 | 50.3 | 48.1-52.6 | 1,197 | 31.6 | 29.6-33.8 | 584 | 18.0 | 16.3-19.9 |
| Diabetes | ||||||||||
| Yes | 577 | 217 | 39.8 | 34.1-45.8 | 264 | 43.2 | 37.5-49.2 | 96 | 17.0 | 12.5-22.7 |
| No | 3,504 | 1,801 | 50.5 | 48.2-52.9 | 1,129 | 31.6 | 29.4-33.8 | 574 | 17.9 | 16.2-19.8 |
| Functional Disability | ||||||||||
| Yes | 1,315 | 502 | 40.1 | 36.3-44.0 | 586 | 40.2 | 36.5-44.0 | 227 | 19.7 | 16.6-23.1 |
| No | 2,635 | 1,457 | 53.6 | 50.9-56.3 | 756 | 29.6 | 27.1-32.1 | 422 | 16.8 | 14.9-18.9 |
| Has two or more chronic diseases† | ||||||||||
| Yes | 1,145 | 444 | 39.7 | 35.7-43.9 | 514 | 43.6 | 39.5-47.9 | 187 | 16.6 | 13.6-20.2 |
| No | 2,941 | 1,577 | 52.2 | 49.7-54.7 | 879 | 29.6 | 27.4-32.0 | 485 | 18.2 | 16.3-20.2 |
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2023 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2023 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 07APR25.
FOLLOW US